Craig M. Kessler

Hematology

3800 Reservoir Rd NW
Washington, DC 20007

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 144 publications

Correction: A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia A.

Correction: A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia A.

Journal: Genes and immunity

Published: September 25, 2025

Building a gene editing lexicon: a model for rare and inherited disorders.

Building a gene editing lexicon: a model for rare and inherited disorders.

Journal: Gene therapy

Published: June 24, 2025

Safety and Use of Eptacog Beta 225 µg/kg in Patients With Haemophilia A or B With Inhibitors.

Safety and Use of Eptacog Beta 225 µg/kg in Patients With Haemophilia A or B With Inhibitors.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: February 13, 2025

Pain Reduction Following Eptacog Beta Treatment of Bleeding Episodes in Adolescents and Adults With Haemophilia A or B Complicated by Inhibitors.

Pain Reduction Following Eptacog Beta Treatment of Bleeding Episodes in Adolescents and Adults With Haemophilia A or B Complicated by Inhibitors.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: January 08, 2025

Development of a novel gene editing lexicon for hemophilia: methodology and results.

Development of a novel gene editing lexicon for hemophilia: methodology and results.

Journal: Research and practice in thrombosis and haemostasis

Published: November 05, 2024

Operationalising a Haemophilia Gene Editing Lexicon for Practical Use.

Operationalising a Haemophilia Gene Editing Lexicon for Practical Use.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: September 17, 2024

A novel gene editing lexicon strategy for the haemophilia community: Research plan for development and preliminary results.

A novel gene editing lexicon strategy for the haemophilia community: Research plan for development and preliminary results.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: June 17, 2024

Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort.

Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort.

Journal: Blood advances

Published: June 06, 2024

Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years.

Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years.

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 05, 2024

Risk of myeloproliferative neoplasms among U.S. Veterans from Korean, Vietnam, and Persian Gulf War eras.

Risk of myeloproliferative neoplasms among U.S. Veterans from Korean, Vietnam, and Persian Gulf War eras.

Journal: American journal of hematology

Published: May 23, 2024

PFA-100 System: A New Method for Assessment of Platelet Dysfunction.

PFA-100 System: A New Method for Assessment of Platelet Dysfunction.

Journal: Seminars in thrombosis and hemostasis

Published: December 13, 2023

A Scan of Pleiotropic Immune Mediated Disease Genes Identifies Novel Determinants of Baseline FVIII Inhibitor Status in Hemophilia-A.

A Scan of Pleiotropic Immune Mediated Disease Genes Identifies Novel Determinants of Baseline FVIII Inhibitor Status in Hemophilia-A.

Journal: Research square

Published: October 27, 2023

Showing 1-12 of 144

Last Updated: 09/26/2026